BIOLASE Granted Regulatory Approval to Sell Waterlase iPlus(TM) All-Tissue Dental Laser Systems in South Korea

IRVINE, CA–(Marketwire – Nov 8, 2011) – BIOLASE Technology, Inc. (NASDAQ: BLTI), a World’s heading dental laser manufacturer and distributor, announced now that it has perceived capitulation from a Korean Food and Drug Administration (“KFDA”) to sell a Waterlase iPlus™ all-tissue dental laser systems via South Korea. South Korea has an estimated 25,000 dentists and 16,000 dental clinics, and their on-going dental practitioners have been quite disposed to adopting high-tech dental equipment, including some-more than 1,000 practices that now use one or some-more BIOLASE dental lasers.

Chairman and CEO Federico Pignatelli said, “The regulatory capitulation of a iPlus in Korea is

Article source:

Shared Post

    Leave a Reply